Shield+ ENT Ablator

About Encision

Encision Inc. is a publicly traded medical device company with a singular mission: to eradicate stray energy burns in laparoscopic surgery through its patented Active Electrode Monitoring (AEM®) technology. The company has achieved significant validation through FDA safety communications, AORN guideline recommendations, and a second-generation Vizient Innovative Technology contract, which bolster its value-based sales strategy. Its business model revolves around selling and reprocessing shielded laparoscopic instruments, arguing that the upfront cost is offset by the avoidance of severe complications, litigation, and improved patient outcomes.

Therapeutic Areas